Skip to main content
The Artificial Sweetener Splenda Promotes Gut Proteobacteria, Dysbiosis, and Myeloperoxidase Reactivity in Crohn's Disease-Like Ileitis.
Enhanced Contribution of HLA in Pediatric Onset Ulcerative Colitis.
Long ncRNA Landscape in the Ileum of Treatment-Naive Early-Onset Crohn Disease.
Subcutaneous Golimumab in Pediatric Ulcerative Colitis: Pharmacokinetics and Clinical Benefit.
Rapid Infliximab Infusion in Children with Inflammatory Bowel Disease: A Multicenter North American Experience.
Utility of neutrophil Fc? receptor I (CD64) index as a biomarker for mucosal inflammation in pediatric Crohn's disease.
Determination of bone age in pediatric patients with Crohn's disease should become part of routine care.
Sex differences in statural growth impairment in Crohn's disease: role of IGF-1.
ImproveCareNow: The development of a pediatric inflammatory bowel disease improvement network.
Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease.